NOV Inhibitors represent a class of chemicals designed to modulate the activity of NOV (Nephroblastoma Overexpressed), a protein encoded by the NOV gene and a member of the CCN family of proteins. This protein family is characterized by their involvement in a wide range of biological processes, including cell proliferation, differentiation, and angiogenesis. The distinct feature of NOV inhibitors lies in their targeted approach towards the interaction of NOV with various signaling pathways and molecular structures within the cell. These inhibitors are not singular in their mechanism of action but are rather a diverse group, each targeting different aspects of NOV's function and its interaction within the cellular environment.
The inhibitors, as conceptualized, work by either directly interfering with the signaling pathways that NOV influences or by disrupting its interactions with other cellular components. For instance, some inhibitors in this class target key signaling pathways such as the Wnt, Notch, Hippo, TGF-beta, MAPK, PI3K/Akt, JAK/STAT, and VEGF pathways. These pathways are crucial for various cellular processes, and NOV is known to interact with or affect these pathways. By inhibiting these pathways, the corresponding NOV inhibitors could, in theory, modulate NOV's role in processes like cell proliferation, differentiation, or angiogenesis. Other members of this class function by hindering NOV's interaction with integrins and heparan sulfate proteoglycans, which are essential for its biological functions. For example, an inhibitor that prevents NOV binding to heparan sulfate proteoglycans could alter the extracellular signaling environment, thereby impacting NOV's function in the cell. Furthermore, some inhibitors in this class might work by modulating the extracellular matrix (ECM) composition, thereby affecting NOV's role in cell-matrix interactions, which are vital for processes like tissue regeneration and repair. Similarly, inhibitors that influence the cell cycle can have an indirect effect on NOV's function in cell proliferation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Inhibits the Wnt signaling pathway, potentially disrupting NOV's role in cell proliferation and differentiation. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Targets the Notch signaling pathway, potentially modulating NOV's interactions in related cellular processes. | ||||||
Verteporfin | 129497-78-5 | sc-475698 sc-475698A | 10 mg 100 mg | $354.00 $2764.00 | 5 | |
Interferes with the Hippo signaling pathway, affecting NOV's role in regulating organ size and cell apoptosis. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $152.00 $214.00 $728.00 $2601.00 $10965.00 $21838.00 $41096.00 | 5 | |
Hinders NOV's binding to heparan sulfate proteoglycans, crucial for its biological functions. | ||||||
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
Disrupts NOV's interaction with integrins, impacting cell adhesion and migration processes. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Modulates the TGF-beta signaling pathway, potentially altering effects related to NOV. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Affects the MAPK pathway, involved in cell growth and differentiation where NOV plays a role. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Targets the PI3K/Akt pathway, influencing cell survival and metabolism, thereby affecting NOV's functions. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
Inhibits the JAK/STAT pathway, potentially modulating NOV's role in cell signaling and immune responses. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Alters the extracellular matrix composition, impacting NOV's role in cell-matrix interactions. | ||||||